Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bausch Health Companies Inc T.BHC

Alternate Symbol(s):  BHC

Healthcare Biotechnology
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with... see more

Bullboard (TSX:BHC)

View:
1 2 3 4 5 Next
Post by Duster340on Jul 31, 2024 12:42pm

Earnings Report 📑🧐

 i would not touch this with a 10 foot pole. Bausch Health Companies (NYSE:BHC) is scheduled to announce Q2 earnings results on Thursday, August 1st, before market open. The consensus ...more  
165
Post by Duster340on Jul 25, 2024 11:53am

Bankruptcy?

Truist Securities analyst Gregory Fraser maintains Bausch Health Companies (NYSE:BHC) with a Hold and lowers the price target from $8 to $7.
96
Post by whytestockson Jul 10, 2024 7:47pm

How to Take Advantage of moves in (BHC)

Just In: $BHC How to Take Advantage of moves in (BHC)2024-07-10 00:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to ...more  
176
Post by whytestockson Jun 14, 2024 4:15pm

Bausch Health Reports Promising R&D Trial Updates on Amiseli

NEWS: $BHC Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare ConferencesLAVAL, QC / ACCESSWIRE / June 14, 2024 / Bausch ...more  
138
Comment by borderguyon Apr 08, 2024 12:59pm

RE:BLCO spinoff

At a ratio of .85 BLCO to BHC shares, a warrant to purchase .85 of a share of BLCO at $4 usd would net BHC over 1.2b usd for debt reduction. Warrants could have an expiry date for early 2025 and would ...more  
213
Discussion
Post by borderguyon Apr 08, 2024 12:26pm

BLCO spinoff

Seem like smaller shareholders of the parent company BHC are giving away the gem of the company. During the orginal IPO of BLCO that just over 11% was sold off at fire sell prices with no benifit to ...more  
294
Discussion
Post by Betteryear2on Jan 18, 2024 10:31am

Receive Registration Certifications in China T.BHC

Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics Markets LAVAL, QC / ACCESSWIRE / January 18, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and ...more  
203
Post by kingscorpionon Nov 08, 2023 10:35pm

Record Q3 revenue for CEMATRIX

Pharmaceutical companies are great investments long term but I bet many of you investors are looking for that 10 bagger. Here it is Cematrix CVX Trading only .195c Just came out with a record breaking ...more  
272
Post by Betteryear2on Jun 30, 2023 8:51am

Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)

LAVAL, QC / ACCESSWIRE / June 30, 2023 / Bausch + Lomb Corporation (NYSE/TSX:BLCO), a subsidiary of Bausch Health Companies Inc. (NYSE/TSX:BHC), announced that it has entered into a definitive ...more  
332
Post by SqueezePlay21on Nov 21, 2022 1:05pm

Massive Short Squeeze Coming on RHT. Don't miss this...

Short interest increased on Reliq Health Technologies right when the company is breaking out. 1st Quarter financial update out in a week. Shorts now over 3.2M and there isn't enough time for them ...more  
264
Discussion
1 2 3 4 5 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities